UnknownNot Applicable

Binaural Sound for Remimazolam Induction

South Korea72 participantsStarted 2023-11-01

Plain-language summary

It is important to decrease the time-to-loss of consciousness and anesthetics dose of remimazolam for general anesthesia induction. We will evaluate the effect of binaural sound for general anestheia induction using remimazolam infusion.

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients scheduled for generla anesthesia
✓. Patients aged 20-60
✓. Patients with American Society of Anesthesiologist physical status classification 1-2
✓. Patients with ideal body weight 50-80 kg

Exclusion criteria

✕. Patients with hearing disability
✕. Patients using opioids or sedatives in 1 week
✕. Patients who are dependent for alcoholics or drugs
✕. Patients with hypersensitivities to remimazolam
✕. Patients with arrhythmia, cardiovascular disease, heart failure, or hypovolemia
✕. Patients with liver failure

What they're measuring

Remimazolam dose for no response to voice

Timeframe: At anesthesia day 0

Trial details

NCT IDNCT06099977

SponsorGangnam Severance Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-10-01

Contact for this trial

Hyun-Chang Kim

82-2-2224-3919 onidori@yuhs.ac

View on ClinicalTrials.gov More General Anesthesia trials